Aveanna Healthcare Q1 EPS of $0.18 Beats by $0.05, Raises Guidance
Aveanna delivered adjusted EPS of $0.18, beating forecasts by $0.05, while revenue rose 15.9% to $647.9 million in Q1. The company raised full-year revenue guidance to $2.56–2.58 billion and lifted adjusted EBITDA outlook to $328–332 million on accelerating 25.2% EBITDA growth.
1. Q1 Financial Performance
The company reported adjusted earnings per share of $0.18, outperforming analyst estimates by $0.05, and generated revenue of $647.9 million, up 15.9% from $559.2 million a year earlier.
2. Guidance Raised
Following the strong start, full-year revenue guidance was increased to $2.56–2.58 billion from $2.54–2.56 billion, and adjusted EBITDA forecast was lifted to $328–332 million from $318–322 million.
3. Segment Growth
All three operating segments contributed to growth, with the PDS division adding $75.7 million, the HHH segment contributing $9.9 million, and the MS unit providing $3.2 million in additional revenue compared to Q1 2025.
4. Management Commentary
CEO Jeff Shaner highlighted the resilience of the business model, noting that the first quarter’s performance demonstrates positive momentum and underpins the revised full-year targets for revenue and adjusted EBITDA.